Conventional DC type 1-cDC1 |
BDCA3+ DC/CD141+ DC |
HLADR+CD11c+CD141+Clec9a+XCR1+CADM1+
|
IRF8, batf3, Bc16, Flt3, CLNK |
Cross presentation of dead cell associated antigens to CD8 T cells, Type III IFN production under TLR-3 triggering |
Conventional DC type 2-CDc2 |
BDCA1 DC/CD1c+ DC |
HLADR+CD11c+CD1c+CD172+
|
IRF4, Notch2, Rbpj, Klf4 |
Activation of CD4 T cells, IL-12 production |
plasmacytoid DC - pDC |
BDCA2+ DC |
HLADR+CD11c-CD123+CD303+CD304+CD45RA+
|
IRF8, Bcl11a, Spi-B, E2-2, Runx1 |
Major producer of the type I IFN, Anti viral immunity |
Langerhans cells-LC |
|
HLADR+CD11c+CD1a+CD207+
|
EPCAM, ABCC4 and BMPR1A |
Major component of skin immunity, |
inflammatory dendritic cells-inf-DC |
MoDCs |
HLADR+CD11c+CD11b+CD206+CD209 +/−
|
MAFB, FCGR2B, TPI1 |
Major source of Nitric oxide and tumor necrosis factor during infection and inflammation |